SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031795
Filing Date
2019-08-13
Accepted
2019-08-13 16:12:00
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 ALT Q2 2019 10Q alt-10q_20190630.htm 10-Q 1636368
2 EX-10.1 alt-ex101_72.htm EX-10.1 90988
3 EX-10.2 alt-ex102_73.htm EX-10.2 18152
4 EX-31.1 alt-ex311_6.htm EX-31.1 18172
5 EX-31.2 alt-ex312_8.htm EX-31.2 17905
6 EX-32.1 alt-ex321_9.htm EX-32.1 6189
7 EX-32.2 alt-ex322_7.htm EX-32.2 6152
8 GRAPHIC gyq5pdilly5r000001.jpg GRAPHIC 8712
  Complete submission text file 0001564590-19-031795.txt   5417442

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT alt-20190630.xml EX-101.INS 898916
10 XBRL TAXONOMY EXTENSION SCHEMA alt-20190630.xsd EX-101.SCH 46209
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20190630_cal.xml EX-101.CAL 55654
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20190630_def.xml EX-101.DEF 156453
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20190630_lab.xml EX-101.LAB 383678
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20190630_pre.xml EX-101.PRE 279435
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 191020753
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences